<p>(*) <i>p</i><0.05 and (**) <i>p</i> <0.01 compared with product C.</p><p>Pharmacokinetic parameters of multi-compounds.</p
Pharmacokinetic parameters of initial high dose rifampicin group in the severe illness group and dos...
<p>Comparison of non-compartmental pharmacokinetic parameters for the white matter measured by ELISA...
In drug discovery and development, the kinetic study of active metabolites plays an important role, ...
<p>Pharmacokinetic parameters for compound 4 and 5 based on oral administration in mice.</p
<p>Pharmacokinetic parameters and their variability in the study population (5th - 95th percentile),...
<p>(a1, a2: HCA; b1, b2: PCA; The most important ingredients influencing the difference between prod...
Pharmacokinetic indices’ mean ± SD for the four meloxicam treatment groups (n = 6 per group).</p
<p>Pharmacokinetic parameters, estimated with the final two-compartment models.</p
<p>For the two compounds whose pharmacokinetics is described by Eqs <a href="http://www.plosone.org/...
<p>(*) <i>P</i><0.05 and (**) <i>P</i><0.01, compared with product C group. (A: <i>AUC</i> between p...
<p>Pharmacokinetic parameters for mice, rats, and dogs obtained by the noncompartmental analysis.</p
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>BLQ; Below the level of quantification</p><p>Pharmacokinetic data are summarized as median (inter...
Much effort in structure-activity relationships has previously been concentrated on the prediction o...
<p>Summary pharmacokinetic parameters in the epithelium and stroma with varying epithelial thickness...
Pharmacokinetic parameters of initial high dose rifampicin group in the severe illness group and dos...
<p>Comparison of non-compartmental pharmacokinetic parameters for the white matter measured by ELISA...
In drug discovery and development, the kinetic study of active metabolites plays an important role, ...
<p>Pharmacokinetic parameters for compound 4 and 5 based on oral administration in mice.</p
<p>Pharmacokinetic parameters and their variability in the study population (5th - 95th percentile),...
<p>(a1, a2: HCA; b1, b2: PCA; The most important ingredients influencing the difference between prod...
Pharmacokinetic indices’ mean ± SD for the four meloxicam treatment groups (n = 6 per group).</p
<p>Pharmacokinetic parameters, estimated with the final two-compartment models.</p
<p>For the two compounds whose pharmacokinetics is described by Eqs <a href="http://www.plosone.org/...
<p>(*) <i>P</i><0.05 and (**) <i>P</i><0.01, compared with product C group. (A: <i>AUC</i> between p...
<p>Pharmacokinetic parameters for mice, rats, and dogs obtained by the noncompartmental analysis.</p
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>BLQ; Below the level of quantification</p><p>Pharmacokinetic data are summarized as median (inter...
Much effort in structure-activity relationships has previously been concentrated on the prediction o...
<p>Summary pharmacokinetic parameters in the epithelium and stroma with varying epithelial thickness...
Pharmacokinetic parameters of initial high dose rifampicin group in the severe illness group and dos...
<p>Comparison of non-compartmental pharmacokinetic parameters for the white matter measured by ELISA...
In drug discovery and development, the kinetic study of active metabolites plays an important role, ...
DOI
Add to ORKG